< Back to latest news & events

News

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

February 2022

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in a competitive environment.

Introduction

In November 2021, US “Interference” proceedings resulted in cancellation of five US patents owned by SNIPR TECHNOLOGIES. It was concluded that the technology claimed in those patents was invented earlier by The Rockefeller University. The University have their own earlier patent filing focused on that technology, which is licenced to ELIGO BIOSCIENCE. The decision is under Appeal.

Perhaps the most commercially relevant lessons to be learned from these proceedings relate to IP strategy creation in a developing and competitive market. Both ELIGO and SNIPR are well known developers of microbiome therapeutics that harness the gene editing specificity of CRISPR. They are clearly competitors and have no doubt been building an IP portfolio and strategy with this in mind.

General IP Strategy aims

IP strategies designed to enable an innovator to dominate a developing and competitive field should have the long-term aim of securing IP rights that map onto the commercial product (providing a monopoly of sales for that product). In the short-term, the strategy should provide tools to raise investment (essentially by suggesting achievability of the long-term aim).

But, how can one build the appropriate strategy if one cannot yet know the specifics of the product that will ultimately go to market?

Read the full article here.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: Summer Case Law Review 2025

As the British summer swings once again between sunburn and showers, it’s a great time to take stock of what the first half of the year has delivered by way …

Read article

Celebrating exam success at HGF!

We are once again delighted to share that our colleagues have achieved success in their recent exams! Their dedication, perseverance, and commitment to professional development have paid off, and we …

Read article

Is the Supreme Court denial in Thatcher’s case a fatal blow against lookalikes?

The dispute between Thatcher’s Cider Company and Aldi Stores Limited has been long running and has sparked legal controversy along the way. On 4th June 2025 the Supreme denied Aldi …

Read article

HGF ranked among Europe’s top patent firms in IP STARS Patent Rankings 2025

HGF has once again made a bold mark in the latest Managing IP Stars 2025 firm rankings, with top-tier recognition across multiple jurisdictions for our patent expertise. This year’s results …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article